BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 19116234)

  • 41. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
    Giovanella L; Ceriani L; Ghelfo A; Keller F
    Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography.
    Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH
    Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lymph node status influences follow-up thyroglobulin levels in papillary thyroid cancer.
    Low TH; Delbridge L; Sidhu S; Learoyd D; Robinson B; Roach P; Sywak M
    Ann Surg Oncol; 2008 Oct; 15(10):2827-32. PubMed ID: 18636294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment.
    Guy A; Hirsch D; Shohat T; Bachar G; Tirosh A; Robenshtok E; Shimon I; Benbassat CA
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4167-73. PubMed ID: 25157544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma.
    Simon D; Goretzki PE; Witte J; Röher HD
    World J Surg; 1996 Sep; 20(7):860-6; discussion 866. PubMed ID: 8678963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck.
    Lee CW; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Jan; 22(1):117-24. PubMed ID: 25034816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Prophylactic Central Compartment Lymph Node Dissection on the Outcome Of Patients With Papillary Thyroid Carcinoma and Synchronous Ipsilateral Cervical Lymph Node Metastases.
    De Napoli L; Matrone A; Favilla K; Piaggi P; Galleri D; Ambrosini CE; Aghababyan A; Papini P; Valerio L; Viola D; Torregrossa L; Ugolini C; Proietti A; Basolo F; Miccoli P; Elisei R; Materazzi G
    Endocr Pract; 2020 Aug; 26(8):807-817. PubMed ID: 33471672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid.
    Ito Y; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    World J Surg; 2004 May; 28(5):498-501. PubMed ID: 15085396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High rate of multifocality and occult lymph node metastases in papillary thyroid carcinoma arising in thyroglossal duct cysts.
    Hartl DM; Al Ghuzlan A; Chami L; Leboulleux S; Schlumberger M; Travagli JP
    Ann Surg Oncol; 2009 Sep; 16(9):2595-601. PubMed ID: 19565286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ; Yoon JH; Han JM; Yim JH; Hong SJ; Song DE; Ryu JS; Kim TY; Shong YK; Kim WB
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Follow-up of children and young adults with differentiated thyroid cancer treated with radioiodine].
    Coronado Poggio M; Martin Curto LM; Marín Ferrer MD; Coya Viña J; Couto Caro RM; Navarro Martínez T; Riesco Almarza G
    Rev Esp Med Nucl; 2003; 22(5):316-26. PubMed ID: 14534007
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence.
    Roh JL; Kim JM; Park CI
    Ann Surg Oncol; 2011 Aug; 18(8):2245-50. PubMed ID: 21327454
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Outcome in cervical recurrences of papillary or follicular thyroid cancer].
    Mirallié E; Hamy A; Floch I; Sagan C; Paineau J; Murat A; Le Néel JC; Visset J
    Ann Chir; 1999; 53(7):577-82. PubMed ID: 10520496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma.
    Lee J; Song Y; Soh EY
    J Korean Med Sci; 2014 Jan; 29(1):48-52. PubMed ID: 24431905
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiated thyroid carcinoma in children and adolescents. Clinical characteristics, treatment and outcome of 15 patients.
    Arici C; Erdogan O; Altunbas H; Boz A; Melikoglu M; Karayalcin B; Karpuzoglu T
    Horm Res; 2002; 57(5-6):153-6. PubMed ID: 12053086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
    Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
    Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary Thyroid Cancer Regardless of T-Staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study.
    Shi X; Huang NS; Lei BW; Song KH; Shi RL; Wei WJ; Hu WP; Dong F; Wang Y; Wang YL; Ji QH
    Ann Surg Oncol; 2018 Aug; 25(8):2316-2322. PubMed ID: 29845406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
    Chow SM; Yau S; Kwan CK; Poon PC; Law SC
    Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.